Thiazol-5-ylmethanamine dihydrochloride

Catalog No.: 
ACYXAN560
CAS No.: 
1215372-00-1
Molecular Formula: 
C4H8Cl2N2S
Molecular Weight: 
187.10
Thiazol-5-ylmethanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$139.00In stockInquiry
10g97%$269.00In stockInquiry
25g97%$670.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameThiazol-5-ylmethanamine dihydrochloride
IUPAC Namethiazol-5-ylmethanamine dihydrochloride
MDL No.MFCD16090013
Molecular FormulaC4H8Cl2N2S
Molecular Weight187.10
SMILESNCC1=CN=CS1.[H]Cl.[H]Cl
InChI KeyURVNRCYESACKMV-UHFFFAOYSA-N
Synonym1215372-00-1 | Thiazol-5-ylmethanamine dihydrochloride | Thiazol-5-yl-methylamine dihydrochloride | (1,3-thiazol-5-yl)methanamine dihydrochloride | 5-(Aminomethyl)thiazole dihydrochloride | 1,3-thiazol-5-ylmethanamine;dihydrochloride | MFCD16090013 | 5-Thiazolemethanam
CAS No.1215372-00-1
PubChem CID49757586

Safety Data

Pictogram
CorrosiveToxic
Signal Word
Danger
Hazard Statement(s)
H301-H318
Precautionary Statement(s)
P264-P270-P280-P301+P310+P330-P305+P351+P338+P310-P405-P501

Synthetic Route by SureRoute

1. ACYXAN560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSOWN560 route compound structure diagram
    ACSOWN56025742-12-5In Stock
  2. Then
  3. ACYXAN560 route product structure diagram
    ACYXAN5601215372-00-1In Stock
Inquiry

2. ACYXAN560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYXAN560 route product structure diagram
    ACYXAN5601215372-00-1In Stock
Inquiry

3. ACYXAN560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYXAN560 route product structure diagram
    ACYXAN5601215372-00-1In Stock
Inquiry

Comments (0)